About Us
ImmuneMed, Inc. utilizes human's own immunity against Infectious Diseases.
With the belief that it is the most basic solution,
we have been researching for many years.
Greeting
ImmuneMed, Inc. was established with the corporate mission of 'contributing to the healthy life of mankind free from infectious diseases.' We would like to ask our researchers who are working with the ever-day and night virus to open new horizons in medical history around the world.
R & D
We are conducting research with the belief that leveraging human immunity is the most basic solution to various diseases. We are developing burfiralimab (formerly, VSF: Virus Suppressing Factor), an antiviral drug candidate.
R & D
We are conducting research with the belief that leveraging human immunity is the most basic solution to various diseases. We are developing and developing VSF (Virus Suppressing Factor), an antiviral source.
News & Press
Press
Release
Release
[Heliyon] hzVSF inhibits hepatitis B virus infection by targeting viral cell entry
2022-05-26
Press
Release
Release
[Journal of Clinical Medicine] COVID-19 Phase 2 Clinical Study Results
2022-05-26
Press
Release
Release
[Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate
development of the treatment
2021-01-08
Press
Release
Release
COVID-19 Phase 2 Clinical Study Approval (Italy), December 18th, 2020
2020-12-21